| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2005, Vol. 105, No. 3, pp. 1060-1067. Prepublished online as a Blood First Edition Paper on October 5, 2004; DOI 10.1182/blood-2003-12-4383.
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY The t-PA 7351C>T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acidFrom the Institute of Clinical Neuroscience, Sahlgrenska University Hospital/Sahlgrenska, Sahlgrenska Academy, Göteborg University, Sweden; the Cardiovascular Institute, Clinical Experimental Research Laboratory, Sahlgrenska University Hospital/Östra, Sahlgrenska Academy, Göteborg University, Sweden; the Department of Medicine, Alfred Medical Research and Education Precinct (AMREP), Monash University, Prahran, Victoria, Australia; and the Department of Clinical Genetics, Sahlgrenska University Hospital/Östra, Göteborg, Sweden.
We have previously identified a common polymorphism at the tissue-type plasminogen activator (t-PA) locus (7351C>T), located within a GC-box in the retinoic acid (RA) and steroid hormone responsive t-PA enhancer. The aim of the present study was to functionally characterize this t-PA variant. Electrophoretic mobility shift assays (EMSAs) using crude nuclear extracts from human endothelial, HeLa, and NT2 neuronal cells revealed a 10-fold greater protein binding affinity to the wild-type C allele compared with the mutant T allele variant. Sp1 and Sp3 were identified as the GC-box binding proteins. Luciferase reporter assays showed that the C allele generated higher transcriptional activity after induction by RA, compared with the T allele variant. Further EMSAs showed that RA treatment enhanced Sp1/Sp3 binding to the GC-box. Formation of the Sp1/Sp3 containing complex was inhibited by antiRA receptor (RAR) antibodies, suggesting that Sp1/Sp3 and RAR interact. The t-PA 7351C>T polymorphism is therefore functional at the level of transcription. The reduced binding affinity of Sp1/Sp3 to the T allele could explain our earlier observations of a reduced t-PA release and an increased risk of myocardial infarction in individuals carrying this allele.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||